<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>NISCAIR Online Periodicals Repository Collection: IJC-B Vol.51B(09) [September 2012]</title>
    <link>http://nopr.niscair.res.in/handle/123456789/14636</link>
    <description />
    <textInput>
      <title>The Collection's search engine</title>
      <description>Search the Channel</description>
      <name>search</name>
      <link>http://nopr.niscair.res.in/simple-search</link>
    </textInput>
    <item>
      <title>Synthesis of racemic and chiral Carvedilol starting from corresponding  5-(chloromethyl)oxazolidin-2-one</title>
      <link>http://nopr.niscair.res.in/handle/123456789/14648</link>
      <description>Title: Synthesis of racemic and chiral Carvedilol starting from corresponding  5-(chloromethyl)oxazolidin-2-one
&lt;br/&gt;
&lt;br/&gt;Authors: Kumar, B Anand; Babu, K Veera; Rao, Rama Koteshwar; Srinivas, Kumbam; Madhusudhan, G; Mukkanti, K
&lt;br/&gt;
&lt;br/&gt;Abstract: The&#xD;
synthesis of racemic Carvedilol ((±)-&lt;b&gt;1&lt;/b&gt;) has been achieved starting from&#xD;
2-(chloromethyl) oxirane ((±)-&lt;b&gt;2&lt;/b&gt;) in a four-step sequence.&#xD;
5-(Chloromethyl) oxazolidin-2-one ((±)-&lt;b&gt;3&lt;/b&gt;) and 5-((9&lt;i style="mso-bidi-font-style:&#xD;
normal"&gt;H&lt;/i&gt;-carbazol-4-yloxy) methyl) oxazolidin-2-one ((±)-&lt;b&gt;4&lt;/b&gt;) are&#xD;
intermediates. A similar sequence starting from (&lt;i style="mso-bidi-font-style:&#xD;
normal"&gt;R&lt;/i&gt;)- or (&lt;i style="mso-bidi-font-style:normal"&gt;S&lt;/i&gt;)-2-(chloromethyl)oxirane&#xD;
&lt;b&gt;2&lt;/b&gt; give corresponding chiral 5-((9&lt;i style="mso-bidi-font-style:normal"&gt;H&lt;/i&gt;-carbazol-4-yloxy)methyl)&#xD;
oxazolidin-2-one &lt;b&gt;4&lt;/b&gt; followed by chiral Carvedilol &lt;b&gt;1&lt;/b&gt;. The synthetic&#xD;
sequence followed avoids the formation of impurity&lt;b style="mso-bidi-font-weight:&#xD;
normal"&gt; B&lt;/b&gt; (&lt;i style="mso-bidi-font-style:normal"&gt;bis&lt;/i&gt; impurity). This&#xD;
approach can be useful for the preparation of pharmaceutically important&#xD;
moieties containing β-amino alcohols without formation of &lt;i style="mso-bidi-font-style:&#xD;
normal"&gt;bis&lt;/i&gt; impurity.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1430-1435</description>
      <pubDate>Wed, 29 Aug 2012 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Facile synthesis of spiro-fused heterocyles by multicomponent reactions under solvent-free conditions</title>
      <link>http://nopr.niscair.res.in/handle/123456789/14647</link>
      <description>Title: Facile synthesis of spiro-fused heterocyles by multicomponent reactions under solvent-free conditions
&lt;br/&gt;
&lt;br/&gt;Authors: Devi, Laishram Ronibala; Singh, Okram Mukherjee
&lt;br/&gt;
&lt;br/&gt;Abstract: A facile synthesis of&#xD;
spiro-fused heterocycles by using three component cyclocondensations of&#xD;
aromatic aldehydes, Meldrum’s acid and urea/thiourea in the presence of&#xD;
catalytic amount of stannous chloride dihydrate under solvent-free conditions&#xD;
is reported.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1426-1429</description>
      <pubDate>Wed, 29 Aug 2012 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Synthesis and evaluation of some novel 2,4-thiazolidinedione derivatives for antibacterial, antitubercular and antidiabetic activities</title>
      <link>http://nopr.niscair.res.in/handle/123456789/14646</link>
      <description>Title: Synthesis and evaluation of some novel 2,4-thiazolidinedione derivatives for antibacterial, antitubercular and antidiabetic activities
&lt;br/&gt;
&lt;br/&gt;Authors: Pattan, Shashikant; Kedar, Manisha; Pattan, Jayashri; Dengale, Santosh; Sanap, Manjusha; Gharate, Utkarsha; Shinde, Punam; Kadam, Sushma
&lt;br/&gt;
&lt;br/&gt;Abstract: A series of&#xD;
2,4-thiazolidinedione have been synthesized and evaluated for antibacterial,&#xD;
antitubercular and antidiabetic activities. The newly synthesized compounds&#xD;
have been characterized by IR, &lt;sup&gt;1&lt;/sup&gt;H NMR and elemental analysis. All&#xD;
compounds have shown promising antibacterial, antitubercular and antidiabetic&#xD;
activities when compared with standard drug Norfloxacin, Streptomycin, and&#xD;
Glibenclamide respectively. Compounds &lt;b&gt;1a, 2a&lt;/b&gt; have shown promising&#xD;
antibacterial activity while compounds &lt;b&gt;1b, 2b &lt;/b&gt;have shown promising&#xD;
antitubercular activity and compounds &lt;b style="mso-bidi-font-weight:normal"&gt;1a&lt;/b&gt;,&#xD;
&lt;b style="mso-bidi-font-weight:normal"&gt;2a&lt;/b&gt; and &lt;b style="mso-bidi-font-weight:&#xD;
normal"&gt;2c&lt;/b&gt; have shown promising antidiabetic activity.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1421-1425</description>
      <pubDate>Wed, 29 Aug 2012 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>One-pot synthesis of coumarin substituted dihydrofurans</title>
      <link>http://nopr.niscair.res.in/handle/123456789/14645</link>
      <description>Title: One-pot synthesis of coumarin substituted dihydrofurans
&lt;br/&gt;
&lt;br/&gt;Authors: Chunduru, Venkata Sreenivasa Rao; Vedula, Rajeswar Rao
&lt;br/&gt;
&lt;br/&gt;Abstract: A sequential one-pot&#xD;
two-step tandem reaction for an efficient synthesis of 2,3-dihydrofurans&#xD;
substituted with 2&lt;i style="mso-bidi-font-style:normal"&gt;H&lt;/i&gt;-benzopyrans has&#xD;
been developed. One-pot reaction of &lt;i style="mso-bidi-font-style:normal"&gt;in&#xD;
situ&lt;/i&gt; formed benzopyran substituted pyridinium ylides with aromatic&#xD;
aldehydes and dimedone gives corresponding 2,3-dihydrofurans in good yields. The&#xD;
structures of the final compounds have been assigned as &lt;i style="mso-bidi-font-style:&#xD;
normal"&gt;trans&lt;/i&gt;-2,3-dihydrofurans on the basis of their NMR spectra.
&lt;br/&gt;
&lt;br/&gt;Page(s): 1417-1420</description>
      <pubDate>Wed, 29 Aug 2012 22:58:59 GMT</pubDate>
    </item>
  </channel>
</rss>

